| Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions F Meng, A Trivino, D Prasad, H Chauhan European Journal of Pharmaceutical Sciences 71, 12-24, 2015 | 178 | 2015 |
| Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques F Meng, U Gala, H Chauhan Drug development and industrial pharmacy 41 (9), 1401-1415, 2015 | 122 | 2015 |
| Qualitative and quantitative methods to determine miscibility in amorphous drug–polymer systems F Meng, V Dave, H Chauhan European Journal of Pharmaceutical Sciences 77, 106-111, 2015 | 117 | 2015 |
| Effect of surfactant level on properties of celecoxib amorphous solid dispersions F Meng, R Ferreira, F Zhang Journal of Drug Delivery Science and Technology 49, 301-307, 2019 | 36 | 2019 |
| Investigation of itraconazole ternary amorphous solid dispersions based on povidone and Carbopol F Meng, J Meckel, F Zhang European journal of pharmaceutical sciences 106, 413-421, 2017 | 32 | 2017 |
| Understanding molecular interactions in rafoxanide–povidone amorphous solid dispersions from ultrafast magic angle spinning NMR M Li, F Meng, Y Tsutsumi, JP Amoureux, W Xu, X Lu, F Zhang, Y Su Molecular Pharmaceutics 17 (6), 2196-2207, 2020 | 31 | 2020 |
| Properties and mechanisms of drug release from matrix tablets containing poly (ethylene oxide) and poly (acrylic acid) as release retardants F Zhang, F Meng, J Lubach, J Koleng, NA Watson European Journal of Pharmaceutics and Biopharmaceutics 105, 97-105, 2016 | 24 | 2016 |
| Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets F Zhang, F Meng, ZY Wang, W Na Drug development and industrial pharmacy 43 (2), 190-203, 2017 | 19 | 2017 |
| Drug–polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide A Trivino, A Gumireddy, F Meng, D Prasad, H Chauhan Drug Development and Industrial Pharmacy, 2019 | 18 | 2019 |
| Self-association of rafoxanide in aqueous media and its application in preparing amorphous solid dispersions F Meng, T Liu, E Schneider, S Alzobaidi, M Gil, F Zhang Molecular pharmaceutics 14 (5), 1790-1799, 2017 | 14 | 2017 |
| Investigating the association mechanism between rafoxanide and povidone F Meng, Z Jing, R Ferreira, P Ren, F Zhang Langmuir 34 (46), 13971-13978, 2018 | 11 | 2018 |
| Supercritical-CO2 foam extrusion of hydroxypropyl methyl cellulose acetate succinate/itraconazole amorphous solid dispersions: processing-structure-property relations SK Rahimi, K O’Donnell, B Haight, A Machado, C Martin, F Meng, T Listro, ... Journal of Pharmaceutical Sciences 110 (4), 1444-1456, 2021 | 7 | 2021 |
| A novel amorphous solid dispersion based on drug–polymer complexation F Meng, R Ferreira, Y Su, F Zhang Drug Delivery and Translational Research 11, 2072-2084, 2021 | 4 | 2021 |
| Investigating crystallization tendency, miscibility, and molecular interactions of drug–polymer systems for the development of amorphous solid dispersions F Meng, SK Paul, S Borde, H Chauhan Drug Development and Industrial Pharmacy 47 (4), 579-608, 2021 | 4 | 2021 |
